SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYoung & Co's Brewery Regulatory News (YNGA)

Share Price Information for Young & Co's Brewery (YNGA)

Share Price is delayed by 15 minutes
Get Live Data
865.00    23.00 (2.73%)
Bid:
840.00
Ask:
865.00
Spread: 25.00 (2.976%)
Market Cap: £508.62m
YNGA Live PriceLast checked at - London Stock Exchange

Intraday Young & Co's Brewery Share Chart

Reopening, Dividend and Financing Update

17 Mar 2021 15:45

RNS Number : 6151S
Young & Co's Brewery PLC
17 March 2021
 

17 March 2021

 

Information within this announcement is deemed by Young's to constitute inside information under the UK Market Abuse Regulation.

 

Young & Co.'s Brewery, P.L.C.

("Young's" or the "Company")

 

Reopening, dividend and financing update

Notification pursuant to AIM Rules 11 and 17

 

Young's provides the following update in light of the ongoing Covid-19 situation and the announcement of the Government's Roadmap for the easing of lockdown restrictions, which should provide some certainty about the Company's plans to reopen its pubs.

 

Reopening

 

Young's expects to reopen about 140 of its managed pubs with outdoor spaces on or around 12 April. Assuming the Roadmap timetable is followed, the rest of the Company's managed estate should open on or around 17 May with restricted indoor trading, ultimately leading to the Company operating under more normal trading conditions from 21 June. If this reopening schedule proceeds as planned, the Company expects to deliver a positive cash flow in May.

 

Dividend

 

In view of the extensive period of closure of the Company's pubs in the current financial year and the expected lower levels of trade during the first three months of the Company's new financial year starting on 30 March 2021 ("FY2021/22"), the Company will not be paying any dividend for the current financial year. The Company's board is very mindful of the importance of dividends to Young's shareholders and intends resuming dividend payments as soon as is appropriate, although no decision has been made when that will be. The Company has, however, agreed with NatWest and the holders of its senior secured notes that any dividend payments during FY2021/22 will not exceed £5 million in aggregate, but there is no restriction on the Company recommending a final dividend with its results for FY2021/22, payable in the following financial year, as normal.

 

Financing

 

The noteholders and the Company's banks have agreed to extend the Company's monthly available liquidity test up to and including March 2022, with a headroom requirement of £25 million.

 

The Company will shortly be seeking an extension, through to November, of its £20 million bilateral revolving credit facility with NatWest.

 

In May, the Company will repay the £30 million borrowed through the Covid Corporate Financing Facility from existing facilities.

 

On the basis of the above, the Company will have committed available facilities of £255 million (inclusive of the £25 million required to meet the available liquidity test referred to above).

 

- Ends -

 

Anthony Schroeder

Company Secretary

17 March 2021 (15:45 GMT)

Tel: 020 8875 7000

 

Contacts:

 

Young & Co.'s Brewery, P.L.C. 020 8875 7000

Patrick Dardis, Chief Executive / Mike Owen, Chief Financial Officer

 

J.P. Morgan Cazenove (AIM nominated adviser and joint broker) 020 7742 4000

James Mitford / Ameya Velhankar

 

Panmure Gordon (joint broker) 020 7886 2500

Erik Anderson

 

MHP Communications 020 3128 8742

Tim Rowntree / Alistair de Kare-Silver youngs@mhpc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEASDXFLAFEFA
Date   Source Headline
21st May 20267:01 amRNSAppointment of Sonita Alleyne as a NED
21st May 20267:00 amRNSFinal Results
5th May 20267:00 amRNSTransaction in Own Shares
28th Apr 20268:00 amRNSReadmission - YOUNG & CO'S BREWERY PLC
28th Apr 20267:00 amRNSAdmission to Trading on the Main Market
23rd Apr 20266:00 pmRNSFTSE Russell Index Changes
23rd Apr 20267:00 amRNSFY26 Trading Update
22nd Apr 202612:00 pmRNSPublication of Prospectus
8th Apr 20267:00 amRNSAcquisition
25th Mar 20267:00 amRNSUpdate on Move to the Main Market
13th Mar 20263:56 pmRNSDirector/PDMR Shareholding
12th Mar 20267:05 amRNSDirectorate change
2nd Feb 20261:51 pmBUSTotal Voting Rights
27th Jan 202612:26 pmBUSHolding(s) in Company
23rd Jan 20264:46 pmBUSHolding(s) in Company
23rd Jan 20264:40 pmBUSHolding(s) in Company
23rd Jan 20264:39 pmBUSDirector/PDMR Shareholding
23rd Jan 20264:36 pmBUSDirector/PDMR Shareholding
22nd Jan 20267:10 amBUSUpdate to Share Buyback Programme
22nd Jan 20267:00 amRNSTrading Update and Proposed Move to Main Market
2nd Jan 20269:27 amBUSTotal Voting Rights
16th Dec 20255:28 pmBUSDirector/PDMR Shareholding
12th Dec 20255:05 pmBUSHolding(s) in Company
4th Dec 20257:00 amBUSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:02 amRNSTotal Voting Rights
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20252:26 pmRNSDirector/PDMR Shareholding
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20252:32 pmRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:56 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSLaunch of Share Buyback Programme
13th Nov 20257:00 amRNSInterim Results
30th Sep 20252:57 pmBUSBlock listing Interim Review
17th Sep 20257:00 amRNSTrading Update
15th Aug 202510:21 amBUSBlock listing Interim Review
18th Jul 20252:43 pmBUSHolding(s) in Company
17th Jul 20257:00 amRNSNotice of Capital Markets Day
9th Jul 20254:58 pmBUSResult of AGM
9th Jul 20257:00 amRNSAGM Update
26th Jun 20257:00 amBUSDirector/PDMR Shareholding
17th Jun 20257:57 amBUSNotice of AGM
5th Jun 20257:00 amRNSDirectorate Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.